| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08af0384f6f51dec690acc32530c81be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
1993-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e8bb3528c5713beae17c0d7895c79fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c5bcfe107824f9a674c0543cfcdbd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55b9ded83a1ba2a36124be8c9a3a7f7a |
| publicationDate |
1994-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0613376-A1 |
| titleOfInvention |
Use of igf-1 |
| abstract |
The invention relates to the use of type 1 insulin-like growth factor (IGF-1) in the production of a medicament for the treatment of type 1 diabetes mellitus. subcutaneous administration, not greater than the dose necessary to obtain a serum IGF-1 level comparable to that of a healthy individual, i.e. a physiological substitute for serum IGF-1 . This treatment is of great interest for the treatment of type 1 diabetes mellitus in children or adolescents and can bring about improvements in growth during puberty. |
| priorityDate |
1992-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |